Oncopeptides AB (OSTO:ONCO) Price-to-Operating-Cash-Flow : (As of Jun. 03, 2025)

View and export this data going back to 2017. Start your Free Trial

What is Oncopeptides AB Price-to-Operating-Cash-Flow?

As of today (2025-06-03), Oncopeptides AB's share price is kr1.588. Oncopeptides AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr-1.23. Hence, Oncopeptides AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Oncopeptides AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

OSTO:ONCO's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Oncopeptides AB's Cash Flow from Operations per share for the three months ended in Mar. 2025 was kr-0.33. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr-1.23.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 52.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 35.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -14.30% per year.

During the past 11 years, Oncopeptides AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.20% per year. The lowest was -105.30% per year. And the median was -40.50% per year.

Oncopeptides AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Oncopeptides AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncopeptides AB Price-to-Operating-Cash-Flow Chart

Oncopeptides AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Oncopeptides AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Oncopeptides AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Oncopeptides AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncopeptides AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncopeptides AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Oncopeptides AB's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Oncopeptides AB Price-to-Operating-Cash-Flow Calculation

Oncopeptides AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.588	/	-1.231
	=

Oncopeptides AB's Share Price of today is kr1.588.
Oncopeptides AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.23.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Oncopeptides AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncopeptides AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (OSTO:ONCO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

0RN4:UK OND:Germany

Address

Luntmakargatan 46, Stockholm, SWE, SE-111 37

Website

https://www.oncopeptides.com

Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Conjugate (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate Melflufen (Pepaxti), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and, in particular, multiple myeloma.